GT Biopharma (GTBP US): Synthetic Expert Call Transcript (12 Oct 2026)
GT Biopharma's TriKEĀ® platform differentiates itself from T-cell engagers (BiTEs) and CAR-NK cell therapies by delivering targeted natural killer...
63 Views
IPO Databook: GT Biopharma (GTBP US) - Oct 2026
GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing and commercializing novel immuno-oncology products using proprietary...
84 Views
No more insights